Unlocking Hope: The Life-Changing Impact of Neutrophil-to-Lymphocyte Ratio in Diabetic Nephropathy

A recent systematic review and meta-analysis suggest that the neutrophil-to-lymphocyte ratio (NLR) may be an effective inflammatory biomarker for identifying patients at heightened risk of diabetic nephropathy (DN) and its progression. DN, a serious complication of diabetes, ranks among the leading causes of chronic kidney disease and end-stage renal failure globally. The challenge of early identification of at-risk patients underscores the ongoing search for simple, cost-effective biomarkers to facilitate risk stratification.

NLR, calculated from routine blood tests, reflects systemic inflammation and has captured attention as a relevant marker across various chronic diseases. This comprehensive analysis involved 39 cohort and case-control studies, encompassing 14,300 participants, and evaluated the connection between NLR and the occurrence, progression, and mortality rates associated with DN. The review included studies published up until May 28, 2025, and was registered with PROSPERO, highlighting its rigorous methodological framework.

The study found a significant connection between elevated NLR levels and the presence of diabetic nephropathy. Notably, patients diagnosed with DN exhibited substantially higher NLR compared to their diabetic counterparts without nephropathy. Pooled analyses indicated more than double the odds of developing DN with elevated NLR levels. This robust association persisted across various analytical methods employed.

For patients already suffering from DN, higher NLR values were also correlated with declining kidney function. Those experiencing renal deterioration registered significantly elevated NLR compared to individuals whose kidney function remained stable, indicating that NLR may hold prognostic utility in tracking disease progression.

While there was a discernable trend indicating higher mortality risk associated with elevated NLR in DN patients, the data did not reach statistical significance. Subgroup analyses revealed that the predictive value of NLR was stronger for patients aged 60 and older and for those with a body mass index of at least 25 kg/m², indicating that NLR could be particularly useful for these populations.

Despite these promising findings, the authors of the review cautioned against overinterpretation, pointing out the considerable heterogeneity in study designs and the potential for publication bias. Variances in patient populations, NLR cut-off values, and analytical methods may have influenced the results.

In conclusion, this study positions NLR as a potential, easily accessible biomarker for identifying patients at a higher risk for the onset and progression of diabetic nephropathy. Nevertheless, the authors emphasize the urgent need for large-scale, well-structured prospective studies aimed at standardizing measurement protocols to confirm its clinical relevance and reliability.

This research underscores the importance of continuous investigation into biomarkers like NLR, which could pave the way for more effective early detection and management of diabetic nephropathy, ultimately reducing the burden of kidney disease linked to diabetes.

Reference: Liu H et al. The predictive value of neutrophil-to-lymphocyte ratio for the occurrence, progression, and mortality of diabetic nephropathy: a systematic review and meta-analysis. Sci Rep. 2026. doi: 10.1038/s41598-025-30680-4.

Original Source: https://www.emjreviews.com/urology/news/elevated-nlr-linked-to-diabetic-nephropathy-risk-and-progression/
Category :
Tags:
Publish Date: 2026-01-10 20:33:00